$25 Million for Stem Cell Research Plus Sharp Criticism of California Stem Cell Board
The California stem cell agency today approved $25.2 million for preclinical research aimed at speeding development of therapies for afflictions that include arthritis, Alzheimer's and “bubble boy” syndrome.
The action came during an agency governing board session that was marked by sharp criticism from an executive with a La Jolla firm associated with …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.